BioDlink Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
594
- Stock Symbol
-
01875
- Share Price
-
$0.43
- (As of Friday Closing)
BioDlink General Information
Description
BioDlink International Co Ltd is an investment holding company. The Company is mainly engaged in research and development (R&D), manufacturing, and marketing of anti-tumor drugs, contract development and manufacturing organization (CDMO), contract manufacturing organization (CMO) business and license-out of self-developed biological drugs. The company has presence in Mainland China, and Others. The company's services includes ADC R&D Service Platform, Chemical based conjugation process development, Developability assessment for drug product, Drug substance analysis, Antibody Manufacturing, Drug product analysis, etc.
Contact Information
Website
www.biodlink.comCorporate Office
- Dongyao Pharmaceutical Co., Ltd., Number 120 Changyang Street, Suzhou Industrial Park
- Suzhou, Jiangsu 215024
- China
Corporate Office
- Dongyao Pharmaceutical Co., Ltd., Number 120 Changyang Street, Suzhou Industrial Park
- Suzhou, Jiangsu 215024
- China
BioDlink Stock Performance
As of 20-Nov-2026, BioDlink’s stock price is $0.43. Its current market cap is $312M with 725M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.43 | $0.42 | $0.22 - $0.75 | $312M | 725M | 454K | -$0.03 |
BioDlink Financials Summary
As of 30-Jun-2026, BioDlink has a trailing 12-month revenue of $72.1M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 311,307 | 234,847 | 172,123 | 168,676 |
| Revenue | 72,101 | 103,965 | 153,067 | 110,338 |
| EBITDA | (21,920) | (1,599) | 14,866 | 1,056 |
| Net Income | (23,287) | (13,957) | 4,844 | (5,337) |
| Total Assets | 172,741 | 179,983 | 206,678 | 201,182 |
| Total Debt | 51,661 | 54,820 | 54,173 | 48,762 |
BioDlink Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioDlink Comparisons
Industry
Financing
Details
BioDlink Competitors (23)
One of BioDlink’s 23 competitors is Biocon, a Formerly PE-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biocon | Formerly PE-Backed | Bengaluru, India | ||||
| Aurobindo Pharma | Corporation | Hyderabad, India | ||||
| Roche | Corporation | Basel, Switzerland | ||||
| Torrent Pharmaceuticals | Corporation | Ahmedabad, India | ||||
| Novartis | Corporation | Basel, Switzerland |
BioDlink Patents
BioDlink Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025067393-A1 | Disaccharide-acylhydrazone or disaccharide-hydrazide linker, glyco-engineered antibody and sugar-chain site-directed antibody-drug conjugate based on same, and use thereof | Inactive | 28-Sep-2023 | ||
| WO-2025067404-A1 | Endoglycosidase s2 mutant, preparation method therefor and use thereof in antibody glycosylation modification | Inactive | 28-Sep-2023 | ||
| WO-2024120526-A1 | Anti-ilt4 antibody as well as preparation method therefor and use thereof | Inactive | 09-Dec-2022 | ||
| WO-2020073883-A1 | Syringe and auxiliary dosing device for syringe | Inactive | 08-Oct-2018 | A61M5/315 |
BioDlink Signals
BioDlink Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioDlink ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
BioDlink Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Yaozhan Pharmaceutical | Suzhou, China | 2021 |
BioDlink FAQs
-
When was BioDlink founded?
BioDlink was founded in 2010.
-
Where is BioDlink headquartered?
BioDlink is headquartered in Suzhou, China.
-
What is the size of BioDlink?
BioDlink has 594 total employees.
-
What industry is BioDlink in?
BioDlink’s primary industry is Drug Discovery.
-
Is BioDlink a private or public company?
BioDlink is a Public company.
-
What is BioDlink’s stock symbol?
The ticker symbol for BioDlink is 01875.
-
What is the current stock price of BioDlink?
As of 20-Nov-2026 the stock price of BioDlink is $0.43.
-
What is the current market cap of BioDlink?
The current market capitalization of BioDlink is $312M.
-
What is BioDlink’s current revenue?
The trailing twelve month revenue for BioDlink is $72.1M.
-
Who are BioDlink’s competitors?
Biocon, Aurobindo Pharma, Roche, Torrent Pharmaceuticals, and Novartis are some of the 23 competitors of BioDlink.
-
What is BioDlink’s annual earnings per share (EPS)?
BioDlink’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process